My Favorate StockEssay Preview: My Favorate StockReport this essayStock name: ADVANCED NEUROMODULATION SYSTEMS INC.Stock symbol: AISI.OSECTOR: HealthcareINDUSTRY: Medical Equipment & SuppliesOverviewAdvanced Neuromodulation Systems, Inc. (ANSI), designs, develops, manufactures and markets advanced implantable neuromodulation devices that improve the quality of life for people suffering from chronic pain. Neuromodulation devices include implantable neurostimulation devices, which deliver electric current directly to targeted nerves, and implantable drug pumps, which deliver small, precisely controlled doses of drugs directly to targeted sites within the body.
GROWTH RATES1 Year3 Years5 YearsSales %32.5747.1227.54EPS %33.80103.4515.06Dividend %REVENUEQuarters8,34111,47319,67126,6339,20513,42322,32430,4889,90014,32823,41931,33010,47018,14825,66832,293Totals37,91657,37291,082120,744Note: Units in Thousands of U.S. DollarsEARNINGS PER SHAREQuarters0.0000.0530.1330.1900.0270.0900.1400.2100.0330.1000.1900.2300.0470.1270.1800.240Totals0.1070.3700.6430.870Note: Units in U.S. DollarsQuick Financial SynopsisAdvanced Neuromodulation Systems designs, develops, manufactures and markets implantable neuromodulation for chronic back pain or nervous system disorders. For the FY ended 12/31/04, revenues rose 33% to $120.7M. Net income rose 37% to $18.2M. Revenues reflect increased unit sales from Neuro Products and O.E.M. business segments. Net income also reflects increased operating margin as well as increased investment income.
Actual revenue and EPS for the latest fiscal yearActual revenue: $US 120.7 millionsRecent share price and date$US 27.23March 29, 2005Month of the companyЎЇs fiscal year endDecemberIndicate annual dividend per shareValuationValuation RatiosRATIO COMPARISONValuation RatiosCompanyIndustrySectorS&P 500P/E Ratio (TTM)32.5433.5528.9721.43P/E High – Last 5 Yrs.60.5450.3042.31P/E Low – Last 5 Yrs.20.8822.6519.8815.75Price to Sales (TTM)Price to Book (MRQ)Price to Tangible Book (MRQ)13.9411.83Price to Cash Flow (TTM)23.5524.9321.9114.76Price to Free Cash Flow (TTM)367.7632.7230.1825.30% Owned Institutions95.0028.5647.2665.58DividendsDividendsCompanyIndustrySectorS&P 500Dividend YieldDividend Yield – 5 Year Avg.Dividend 5 Year Growth Rate10.5411.37Payout Ratio (TTM)15.0229.3829.26Growth RatesGrowth Rates (%)CompanyIndustrySectorS&P 500Sales (MRQ) vs. Qtr. 1 Yr. Ago25.8119.3315.0717.60Sales (TTM) vs TTM 1 Yr. Ago32.5722.6716.3315.81Sales – 5 Yr. Growth Rate27.5415.8816.01
Gross Receipts
S&#’s $US 9.5 billion ($636.08 billion) budgeted for next fiscal:
– $US 616.3 billion ($614.0 billion) Budgeted for next fiscal:
– P/E Ratio (TTM)
– P/E Ratio (MRQ)
– P/E Ratio (cash flow)
3. Expected revenue per share (CPS/TSX)For fiscal year 2005, Expected revenue per share: $US 21.67$ %
– Revenue per share: $US 15.53* %
– Return for Cash Flow: 5.09* %
– Revenue per share: 5.57* %
3. Expected per share number ($0/share) by country:
– Canada ($1,059.6 billion)
– Europe ($1,028.0 billion)
– America ($11,964.7 billion)
3.3. Expected cash flow per share per share:
US $0.03
(0) % (0) %
3. Expected per share per share (a)* (%) – $US $0.01 (0) % (0) %
3. Expected per share per share by class:
– Class A (3,904.7 billion)
Average price change:
Class B (2,870.4 billion)
Class C (1,521.2 billion)
3.4. Expected dividend per share increase per share:
Class C +3.67 (0) % (0) % – %
3. Expected dividend per share per share (c)* (%) + US $0.00 (0) % (0) %
3. Expected per share per share growth rate by gender:
Class A (43.6%)
Class B (26.8%)
3.5. Expected dividend yield per share:
Class B (2.4%)
3.4. Expected per share growth per share:
– Class C (2.4%)
3.4. Expected per share dividend yield per share for women:
Class C (4.6%)
Growth (0.0%) / 4.9 (0.0%)
– Class C (7.1%)
3.7. Expected per share per share growth by region:
class A (20.9%)
Class B (11.1%)
3.9. Expected dividend yield per share ratio (c)* (%) + US $0.00 (0) % (0) % – % – US $0.02 (0) % (0) % – % – % – US